(Reuters) -British autocatalyst maker Johnson Matthey said on Monday it would review its executive pay and cut its capital expenditure in its hydrogen technologies business to boost its cash following ...

Even with WrestleMania 41 taking place during Easter weekend this year, the WWE does not need Dwayne "The Rock" Johnson for ...

The medical device specialist's market cap currently tops $215 billion, meaning it would need to achieve a compound annual ...

The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates ...

Promising a “fight” to protect all Chicagoans, Mayor Brandon Johnson said yesterday he has not reached out to the White House in the face of Republican President Donald Trump’s ongoing threats against ...

Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

Intuitive Surgical isn't just placing lots of next-generation surgical systems, it's selling heaps of instruments that must be replaced following each procedure. Fourth-quarter instrument and ...

In today’s complex business landscape, strategic communication and reputation management are not optional—they are critical ...

Brian Johnson, currently the specialty grocery chain’s chief operating officer, will assume leadership of the company on Feb.

Johnson & Johnson (NYSE: JNJ) is an elite dividend stock. The healthcare giant has increased its dividend payment for 62 years in a row. The iconic healthcare company backs its high-yielding payout ...